Elli Papaemmanuil1,2, Moritz Gerstung1, Lars Bullinger3, Verena I. Gaidzik3, Peter Paschka3, Nicola D. Roberts1, Nicola Potter4, Michael Heuser5, Felicitas Thol5, Niccolò Bolli1,6,7, Gunes Gundem1, Peter Van Loo1,8, Iñigo Martincorena1, Peter Ganly9, Laura Mudie1, Stuart McLaren1, Sarah O’Meara1, Keiran Raine1, David R. Jones1, Joshua M. Stuart1, Adam P. Butler1, Mel Greaves4, Arnold Ganser5, Konstanze Döhner3, Richard F. Schlenk3, Hartmut Döhner3, Peter J. Campbell1,9
1Cancer Genome Project, Wellcome Trust Sanger Institute
2Departments of Epidemiology and Biostatistics and Cancer Biology, the Center for Molecular Oncology and the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York
3Department of Internal Medicine III, Ulm University, Ulm
4Hinxton, the Centre for Evolution and Cancer, Institute of Cancer Research, London
5Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover
6Department of Haematology, University of Cambridge, Cambridge
7Division of Hematology, Fondazione IRCCS, Istituto Nazionale dei Tumori, and Department of Oncology and Onco-Hematology, University of Milan, Milan
8Department of Human Genetics, University of Leuven, Leuven, Belgium
9Department of Pathology, University of Otago, Christchurch, New Zealand
